Šťastná-Marková, M.; Hamšíková, E.; Hainz, P.; Hubáček, P.; Kroutilová, M.; Kryštofová, J.; Ludvíková, V.; Musil, J.; Pecherková, P.; Saláková, M.;
et al. Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT. Vaccines 2021, 9, 1226.
https://doi.org/10.3390/vaccines9111226
AMA Style
Šťastná-Marková M, Hamšíková E, Hainz P, Hubáček P, Kroutilová M, Kryštofová J, Ludvíková V, Musil J, Pecherková P, Saláková M,
et al. Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT. Vaccines. 2021; 9(11):1226.
https://doi.org/10.3390/vaccines9111226
Chicago/Turabian Style
Šťastná-Marková, Markéta, Eva Hamšíková, Petr Hainz, Petr Hubáček, Marie Kroutilová, Jitka Kryštofová, Viera Ludvíková, Jan Musil, Pavla Pecherková, Martina Saláková,
and et al. 2021. "Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT" Vaccines 9, no. 11: 1226.
https://doi.org/10.3390/vaccines9111226
APA Style
Šťastná-Marková, M., Hamšíková, E., Hainz, P., Hubáček, P., Kroutilová, M., Kryštofová, J., Ludvíková, V., Musil, J., Pecherková, P., Saláková, M., Šroller, V., Vydra, J., & Němečková, Š.
(2021). Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT. Vaccines, 9(11), 1226.
https://doi.org/10.3390/vaccines9111226